Grand Hôpital de Charleroi, site Notre Dame

Charleroi 6000

0 studies enrolling now · 5 studies all time

What they study most

Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Breast Cancer, Castration-Resistant Prostatic Neoplasms, Disease Progression, Metastatic Breast Cancer, Solid Tumor

Studies at this site

• Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer — Running, not enrolling
• SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors — Running, not enrolling
• Treatment Resistance Following Anti-cancer Therapies — Stopped early
• Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors — Stopped early
• A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer — Completed